For nearly a decade, Dendrite Clinical Systems and Device Access UK have been combining their expertise in clinical registries and market access and reimbursement, respectively, to expedite the regulatory processes for MedTech companies to get their technologies to patients. Working in conjunction with small, medium and large multinational companies, the partnership has enabled clients to record, collect and analyse real-world evidence and present data that adheres to the necessary regulatory guidance and requirements.
12 February 2021
Dendrite Clinical Systems’ innovative “Intellect Web” software has been utilised by several national and international organisations to establish web-based registries to collect data from patients with COVID-19.
21 January 2021
Dendrite Clinical Systems is delighted to report that our Managing Director, Dr Peter Walton, has published a chapter discussing the value of clinical registries in new publication on Laparoscopic Sleeve Gastrectomy (LSG). In his Chapter, Dr Peter Walton outlines value of national bariatric registries and their capability to deliver evidence on a global basis, as well as providing some practical perspectives on best practice when setting out to start a national registry and how to keep a good registry going.
10 January 2021
Dendrite Clinical Systems and the Institute for Health Research (IGES) in Berlin, Germany, have initiated the Outpatient Treatment of COVID-19 Infections (ABC-19) study, to record data on the treatment of COVID-19 patients and discover more about the outpatient course of the disease, the individual risk factors of patients that contribute to severe COVID-19 courses and the procedures of general practitioners (GPs).
11 December 2020
Dendrite Clinical Systems, in conjunction with the British Obesity and Metabolic Surgery Society (BOMSS), have published the Third National Bariatric Surgery Registry Report that highlights the safety and effectiveness of bariatric and metabolic surgery in the UK. The report uses data from the National Bariatric Surgery Registry (NBSR), a decade long research collaboration between BOMSS and Dendrite Clinical Systems.
13 October 2020
Researchers at the University College London and University College London Hospitals NHS Foundation Trust), London, UK, have reported that the vast majority of participants with new onset loss of smell were positive for COVID19, and this acute loss of sense of smell needs to be considered globally as a criterion for self-isolation, testing and contact tracing in order to contain the spread of COVID-19.
2 October 2020